Monumental progress in the areas of molecular biology, virology, gene transfer technology, and human genome mapping are providing the foundation for a new area of biomedical research - somatic gene therapy. This new approach to therapy holds tremendous promise for treating, curing and potentially preventing a large spectrum of acquired and inherited diseases. The University of Pennsylvania has an excellent track record in the development of experimental models of gene therapy, in part through integrated programs in animal models at the School of Veterinary Medicine. The recruitment of Dr. James M. Wilson as the Director of a newly formed institute for Human Gene Therapy (IHGT), along with the commitment of 25 new faculty positions and 40,000 sq ft of laboratory space to this institute, is further indication of the commitment of the University of Pennsylvania to the field of gene therapy. The IGHT provides an excellent infrastructure on which to build multidisciplinary programs in gene therapy. This P30 proposal requests support for research in """"""""Gene Therapy of Cystic Fibrosis and Genetic Diseases."""""""" The foundation of the grant is a series of core laboratories which currently exist in the IHGT. These provide technical support for the basic and clinical development of gene therapies. They include a Vector Core, Cell Morphology Core, Animal Models Core, Human Applications Laboratory, and Ion Transport Core. Approximately 50 faculty with funded research in areas relevant to the grant have been recruited to participate. These individuals form the basis for major research programs in Cystic Fibrosis, Vectors, and Genetic Diseases. A general solicitation for Development and Feasibility proposals was sent to the Faculty at the University of Pennsylvania, Wistar institute, Children's Hospital of Philadelphia, Children's Seashore House, Medical College of Pennsylvania, Hannamahn Hospital, and St. Christopher's Hospital. We received 42 proposals and selected 12 outstanding applications for inclusion in the grant.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK047757-02
Application #
2147590
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Project Start
1993-09-30
Project End
1998-08-31
Budget Start
1994-09-30
Budget End
1995-08-31
Support Year
2
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Svidritskiy, Egor; Korostelev, Andrei A (2018) Conformational Control of Translation Termination on the 70S Ribosome. Structure 26:821-828.e3
Svidritskiy, Egor; Korostelev, Andrei A (2018) Mechanism of Inhibition of Translation Termination by Blasticidin S. J Mol Biol 430:591-593
Gurda, Brittney L; De Guilhem De Lataillade, Adrien; Bell, Peter et al. (2016) Evaluation of AAV-mediated Gene Therapy for Central Nervous System Disease in Canine Mucopolysaccharidosis VII. Mol Ther 24:206-216
Svidritskiy, Egor; Madireddy, Rohini; Korostelev, Andrei A (2016) Structural Basis for Translation Termination on a Pseudouridylated Stop Codon. J Mol Biol 428:2228-36
Greig, Jenny A; Calcedo, Roberto; Grant, Rebecca L et al. (2016) Intramuscular administration of AAV overcomes pre-existing neutralizing antibodies in rhesus macaques. Vaccine 34:6323-6329
McClain, Lauren E; Davey, Marcus G; Zoltick, Phillip W et al. (2016) Vector serotype screening for use in ovine perinatal lung gene therapy. J Pediatr Surg 51:879-84
Calcedo, Roberto; Wilson, James M (2016) AAV Natural Infection Induces Broad Cross-Neutralizing Antibody Responses to Multiple AAV Serotypes in Chimpanzees. Hum Gene Ther Clin Dev 27:79-82
Svidritskiy, Egor; Korostelev, Andrei A (2015) Ribosome Structure Reveals Preservation of Active Sites in the Presence of a P-Site Wobble Mismatch. Structure 23:2155-61
Wang, Lili; Bell, Peter; Somanathan, Suryanarayan et al. (2015) Comparative Study of Liver Gene Transfer With AAV Vectors Based on Natural and Engineered AAV Capsids. Mol Ther 23:1877-87
Calcedo, Roberto; Franco, Judith; Qin, Qiuyue et al. (2015) Preexisting Neutralizing Antibodies to Adeno-Associated Virus Capsids in Large Animals Other Than Monkeys May Confound In Vivo Gene Therapy Studies. Hum Gene Ther Methods 26:103-5

Showing the most recent 10 out of 231 publications